These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2652317)

  • 1. Pharmacokinetics and metabolism of Navelbine.
    Krikorian A; Rahmani R; Bromet M; Bore P; Cano JP
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):21-5. PubMed ID: 2652317
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacokinetics of vinca alkaloids].
    Rahmani R; Samak R; Bore P; Cano JP
    Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
    Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
    Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.
    Nelson RL; Dyke RW; Root MA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():17-24. PubMed ID: 7438117
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.
    Sethi VS; Surratt P; Spurr CL
    Cancer Chemother Pharmacol; 1984; 12(1):31-5. PubMed ID: 6690071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in vinca-alkaloids: Navelbine.
    Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
    Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis of Navelbine prototype of a new series of vinblastine derivatives.
    Potier P
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):2-4. PubMed ID: 2540531
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections.
    Rahmani R; Martin M; Favre R; Cano JP; Barbet J
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1409-17. PubMed ID: 6542010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hepatic uptake of two vinca alkaloids: navelbine and vincristine.
    Rahmani-Jourdheuil D; Coloma F; Placidi M; Rahmani R
    J Pharm Sci; 1994 Apr; 83(4):468-71. PubMed ID: 8046598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
    Zhou XJ; Landi H; Breillout F; Rahmani R
    Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of navelbine after oral administration in cancer patients.
    Zhou XJ; Boré P; Monjanel S; Sahnoun Z; Favre R; Durand A; Rahmani R
    Cancer Chemother Pharmacol; 1991; 29(1):66-70. PubMed ID: 1742851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and tissue levels of [3H]vindesine in rats.
    Culp HW; Daniels WD; McMahon RE
    Cancer Res; 1977 Sep; 37(9):3053-6. PubMed ID: 884663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Affinity of 99mTc-N,N-bis-(carboxymethyl) aminoacetylproline for tumors in mice].
    Tao ZQ; Chen ZJ; Zhang JS; Ding GS
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):170-3. PubMed ID: 2946159
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
    Rahmani R; Bruno R; Iliadis A; Favre R; Just S; Barbet J; Cano JP
    Cancer Res; 1987 Nov; 47(21):5796-9. PubMed ID: 3664483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vindesine and vincristine in humans.
    Owellen RJ; Root MA; Hains FO
    Cancer Res; 1977 Aug; 37(8 Pt 1):2603-7. PubMed ID: 872088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.